These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4394766)

  • 1. 2-mercaptobenzothiazole, an inhibitor of dopamine beta-hydroxylase.
    Johnson GA; Boukma SJ; Platz PA
    J Pharm Pharmacol; 1970 Sep; 22(9):710-2. PubMed ID: 4394766
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral and brain catecholamine depleting actions of U-14,624, an inhibitor of dopamine beta-hydroxylase.
    Von Voigtlander PF; Moore KE
    Proc Soc Exp Biol Med; 1970 Mar; 133(3):817-20. PubMed ID: 5435575
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of amphetamine derivatives on brain dopamine and noradrenaline.
    Breese GR; Kopin IJ; Weise VK
    Br J Pharmacol; 1970 May; 38(3):537-45. PubMed ID: 4909707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inhibition of dopamine beta-hydroxylase by 1-phenyl-3-(2-thiazolyl)-2-thiourea (U-14,624).
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1970 Jan; 171(1):80-7. PubMed ID: 5410940
    [No Abstract]   [Full Text] [Related]  

  • 5. L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase.
    Strömberg U; Svensson TH
    Psychopharmacologia; 1971; 19(1):53-60. PubMed ID: 5089105
    [No Abstract]   [Full Text] [Related]  

  • 6. 4,4,6-trimethyl-3,4-dihydropyrimidine-2-thiol, an effective inhibitor of dopamine-beta-hydroxylation in vivo.
    Porter CC; Torchiana ML
    Biochem Pharmacol; 1971 Jan; 20(1):183-91. PubMed ID: 4398314
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylethyldithiocarbamate: a new dopamine-beta-hydroxylase inhibitor.
    Jonsson J; Grobecker H; Gunne LM
    J Pharm Pharmacol; 1967 Mar; 19(3):201-3. PubMed ID: 4382347
    [No Abstract]   [Full Text] [Related]  

  • 8. Importance of noradrenaline found in a functional pool in maintaining spontaneous locomotor activity in rats.
    Chan OL; Webster RA
    Br J Pharmacol; 1971 Apr; 41(4):700-8. PubMed ID: 5579467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine hydroxylase inhibitors.
    Moore KE; Dominic JA
    Fed Proc; 1971; 30(3):859-70. PubMed ID: 4324974
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of dopamine beta-hydroxylase by aromatic and alkyl thioureas.
    Johnson GA; Boukma SJ; Kim EG
    J Pharmacol Exp Ther; 1969 Aug; 168(2):229-34. PubMed ID: 5803305
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of dopamine -hydroxylase by 5-phenoxymethyl-2-oxazolidinethiones.
    Johnson GA; Kim EG; Boukma SJ; Lednicer D; Youngdale GA
    J Med Chem; 1972 Mar; 15(3):327-9. PubMed ID: 5059221
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-hydroxyindole levels in rat brain after inhibition of dopamine -hydroxylase.
    Johnson GA; Kim EG; Boukma SJ
    J Pharmacol Exp Ther; 1972 Mar; 180(3):539-46. PubMed ID: 5012781
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of false transmitters on norepinephrine synthesis.
    Kopin IJ; Weise VK; Sedvall GC
    J Pharmacol Exp Ther; 1969 Dec; 170(2):246-52. PubMed ID: 4311320
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 15. Behavioral and catecholamine depleting effects of alpha-methyl-5-hydroxytryptophan.
    Dominic JA; Moore KE
    Eur J Pharmacol; 1969 Dec; 8(3):292-5. PubMed ID: 5308817
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of dopamine beta-hydroxylase by fusaric acid (5-butylpicolinic acid) in vitro and in vivo.
    Nagatsu T; Hidaka H; Kuzuya H; Takeya K; Umezawa H
    Biochem Pharmacol; 1970 Jan; 19(1):35-44. PubMed ID: 5507649
    [No Abstract]   [Full Text] [Related]  

  • 17. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative aspects of the replacement of norepinephrine by dopamine as a sympathetic transmitter after inhibition of dopamine-beta-hydroxylase by disulfiram.
    Thoenen H; Haefely W; Gey KF; Huerlimann A
    J Pharmacol Exp Ther; 1967 May; 156(2):246-51. PubMed ID: 6026255
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the action of some psychoactive drugs on central noradrenaline neurons after inhibition of dopamine-beta-hydroxylase.
    Corrodi H; Fuxe K; Ljungdahl A; Ogren SO
    Brain Res; 1970 Dec; 24(3):451-70. PubMed ID: 5494534
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.